Your browser doesn't support javascript.
loading
Local injection of micro-dose guselkumab for palmoplantar pustulosis after partial failure of systemic ixekizumab treatment.
Zhou, Chaojing; Chen, Dandan; Diao, Ziyue; Wang, Yufei; Hou, Yiyun; Yin, ZhiQiang.
Afiliación
  • Zhou C; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Chen D; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Diao Z; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Wang Y; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Hou Y; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Yin Z; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Australas J Dermatol ; 65(3): e75-e76, 2024 May.
Article en En | MEDLINE | ID: mdl-38439213
ABSTRACT
We present a palmoplantar pustulosis case partially resistant to systemic IL-17A inhibitor (ixekizumab) treatment, and then receiving a local injection of 0.1 mL micro-dose (1 mg) IL-23 inhibitor (guselkumab) every 4 weeks for four times. The paradoxical lesion disappeared rapidly following local injection and there was no recurrence after 8 weeks of drug withdrawal. This is the first clinical report on the treatment of palmoplantar pustulosis by local injection of micro-dose guselkumab.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Anticuerpos Monoclonales Humanizados Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Australas J Dermatol Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Anticuerpos Monoclonales Humanizados Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Australas J Dermatol Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia